- Home
- BBIO vs EAD Comparison
BBIO vs EAD Comparison
Compare BBIO & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- EAD
- Stock Information
- Founded
- BBIO 2015
- EAD 2003
- Country
- BBIO United States
- EAD United States
- Employees
- BBIO N/A
- EAD N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- EAD Finance/Investors Services
- Sector
- BBIO Health Care
- EAD Finance
- Exchange
- BBIO Nasdaq
- EAD Nasdaq
- Market Cap
- BBIO 8.0B
- EAD 406.6M
- IPO Year
- BBIO 2019
- EAD N/A
- Fundamental
- Price
- BBIO $43.40
- EAD $7.04
- Analyst Decision
- BBIO Strong Buy
- EAD
- Analyst Count
- BBIO 14
- EAD 0
- Target Price
- BBIO $58.85
- EAD N/A
- AVG Volume (30 Days)
- BBIO 3.3M
- EAD 178.9K
- Earning Date
- BBIO 07-31-2025
- EAD 01-01-0001
- Dividend Yield
- BBIO N/A
- EAD 8.91%
- EPS Growth
- BBIO N/A
- EAD N/A
- EPS
- BBIO N/A
- EAD N/A
- Revenue
- BBIO $127,415,000.00
- EAD N/A
- Revenue This Year
- BBIO $102.05
- EAD N/A
- Revenue Next Year
- BBIO $54.69
- EAD N/A
- P/E Ratio
- BBIO N/A
- EAD N/A
- Revenue Growth
- BBIO N/A
- EAD N/A
- 52 Week Low
- BBIO $21.72
- EAD $5.69
- 52 Week High
- BBIO $45.48
- EAD $6.81
- Technical
- Relative Strength Index (RSI)
- BBIO 63.17
- EAD 78.09
- Support Level
- BBIO $41.80
- EAD $6.83
- Resistance Level
- BBIO $45.48
- EAD $7.18
- Average True Range (ATR)
- BBIO 1.51
- EAD 0.04
- MACD
- BBIO -0.08
- EAD 0.02
- Stochastic Oscillator
- BBIO 63.36
- EAD 90.00
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.